Bakuchiol for Hyperpigmentation: The Plant-Based Retinol Alternative Revolutionizing Anti-Ageing Formulation Science

What Is Bakuchiol? The Botanical Source and Chemical Identity

Bakuchiol (CAS 10309-37-2) is a meroterpene phenol extracted from the seeds and leaves of Psoralea corylifolia (babchi plant), a medicinal herb indigenous to Asia and widely used in Ayurvedic and Traditional Chinese Medicine for centuries. Its molecular formula is C18H26O, bearing a structural resemblance to resveratrol. In August 2022, China’s National Medical Products Administration (NMPA) approved bakuchiol for cosmetic use, removing the final regulatory barrier for large-scale commercial adoption in the Chinese market.

Retinol-Like Gene Regulation Without Retinol Binding

The foundational study establishing bakuchiol’s mechanism of action was published by Chaudhuri and Bojanowski in International Journal of Cosmetic Science (2014). Using human dermal fibroblasts and a whole-genome microarray approach, the researchers demonstrated that bakuchiol upregulates the same suite of anti-ageing genes as retinol—including COL1A1 (Type I collagen), COL3A1 (Type III collagen), ELN (elastin), and FBX4—without binding to retinoic acid receptors (RARs). This retinol-like functional behaviour, achieved through a distinct molecular pathway, is what positions bakuchiol as a true retinol functional analogue rather than a weak retinoid derivative.

The key distinguishing feature: bakuchiol activates collagen-promoting gene expression via RAR-independent signalling cascades, bypassing the classical retinol→retinal→retinoic acid→RAR transcriptional pathway. This explains why bakuchiol produces minimal irritation compared to retinol, which requires conversion to retinoic acid—a process that generates oxidative byproducts and triggers the retinoid receptor cascade directly.

Clinical Evidence: The Dhaliwal RCT

The most rigorous clinical evidence for bakuchiol comes from a prospective, randomized, double-blind, split-face study conducted by Dhaliwal et al. and published in The British Journal of Dermatology (2019). Forty-four participants applied 0.5% bakuchiol cream to one side of the face and 0.5% retinol cream to the other, twice daily for 12 weeks.

Key outcomes documented:

• Wrinkle reduction: Both bakuchiol and retinol significantly reduced wrinkle surface area and hyperpigmentation from baseline (p < 0.05). Bakuchiol showed comparable efficacy to retinol for fine line improvement.
• Pigmentation: Both treatments significantly improved pigmentation intensity as measured by chromameter readings.
• Photoageing index: Both treatments reduced the total photoageing score on the Glogau classification scale.
• Skin tolerance: Significantly fewer participants reported facial desquamation (skin flaking) in the bakuchiol group compared to the retinol group (p < 0.05).

The study concluded that bakuchiol is clinically comparable to retinol for anti-photoageing efficacy, with a superior tolerability profile—particularly relevant for sensitive skin types and daytime use scenarios.

Anti-Inflammatory and MMP Inhibition Mechanisms

Beyond collagen synthesis, bakuchiol addresses a second pathway of skin ageing: extracellular matrix degradation. Matrix metalloproteinases (MMPs)—particularly MMP-1, MMP-3, and MMP-9—are enzymes released by UV-irradiated keratinocytes and fibroblasts that cleave collagen and elastin fibres. In vitro studies using human dermal fibroblasts have demonstrated that bakuchiol suppresses UV-induced MMP-1 expression via inhibition of AP-1 (Activator Protein-1) transcription factor activation, a mechanism shared with topical retinoids but without the associated irritation.

Additionally, bakuchiol exhibits broad anti-inflammatory activity. Research published in Inflammation (Springer Nature, 2016) confirmed that bakuchiol significantly reduces pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6 in lipopolysaccharide-stimulated macrophages. For skin formulation science, this anti-inflammatory profile is particularly relevant for post-procedure skin care and for consumers experiencing inflammatory hyperpigmentation (such as post-acne marks and UV-induced melanogenesis).

Formulation Considerations: Concentration, Stability, and Delivery

Effective bakuchiol formulations typically range from 0.5% to 2.0%. The 0.5% concentration is supported by clinical evidence from the Dhaliwal RCT. Concentrations above 1% may increase the risk of mild contact reactions in sensitized skin types—formulators should conduct repeat insult patch tests (RIPT) when exceeding 1%.

Chemical stability is a significant advantage of bakuchiol over retinol: bakuchiol demonstrates superior photostability and does not generate the same oxidation cascade under UV exposure. This allows for daytime formulations without the mandatory photoprotection requirements that limit retinol’s use window. Bakuchiol is oil-soluble, making it compatible with anhydrous serums, facial oils, and emulsions with oil phases. It pairs particularly well with squalane, jojoba oil, and medium-chain triglyceride (MCT) carriers.

Synergistic combinations to consider for advanced formulations:

• Bakuchiol + Niacinamide: Niacinamide supports barrier repair and inhibits melanosome transfer; bakuchiol drives cellular renewal. Together they address both pigmentation synthesis and pigmented cell turnover pathways.
• Bakuchiol + Tranexamic Acid: Tranexamic acid inhibits plasmin-mediated melanin transfer from melanocytes to keratinocytes; bakuchiol accelerates epidermal turnover to expel pigmented keratinocytes. This dual-pathway approach targets melasma and post-inflammatory hyperpigmentation.
• Bakuchiol + Centella asiatica: Madecassoside and asiaticoside provide complementary wound-healing and anti-inflammatory support, reducing the risk of post-renewal erythema.

Regulatory Status and Southeast Asian Market Context

Bakuchiol holds INCI status and is approved for cosmetic use across major markets including the EU (under EU Cosmetics Regulation 1223/2009), the US (FDA inventory), and China (NMPA approved since August 2022). In the Southeast Asian market—particularly Indonesia, Thailand, Vietnam, and the Philippines, where consumers increasingly seek gentle yet efficacious botanicals—bakuchiol occupies a compelling position as a science-backed natural retinol alternative free from the regulatory constraints and irritation liabilities of conventional retinoids.

The clean-label consumer segment in Southeast Asia shows strong affinity for plant-derived actives with traditional medicine heritage. Bakuchiol’s Ayurvedic provenance, combined with peer-reviewed clinical evidence, makes it an effective marketing narrative for premium anti-ageing and brightening formulations targeting this demographic.

Conclusion

Bakuchiol represents a validated botanical alternative to retinol, operating through a distinct but functionally equivalent gene-regulation pathway. Clinical evidence from randomized controlled trials demonstrates comparable anti-wrinkle and anti-hyperpigmentation efficacy with significantly improved tolerability. For formulation scientists developing next-generation anti-ageing products, bakuchiol offers a compelling combination of botanical heritage, molecular mechanism depth, clinical validation, and regulatory accessibility—making it a cornerstone ingredient for the Southeast Asian skincare market’s growing demand for gentle yet scientifically substantiated actives.

References

1. Chaudhuri RK, Bojanowski K. Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects. Int J Cosmet Sci. 2014;36(3):221-230. doi:10.1111/ics.12117
2. Dhaliwal S, Rybak I, Ellis SR, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. Br J Dermatol. 2019;180(2):289-296. doi:10.1111/bjd.16953
3. Park MA, et al. Bakuchiol protects against acute lung injury in septic mice. Inflammation. 2016;39(6):1854-1862. doi:10.1007/s10753-016-0481-5
4. Ma Q, Bian M, Gong G, et al. Synthesis and evaluation of bakuchiol derivatives as potent anti-inflammatory agents in vitro and in vivo. J Nat Prod. 2022;85(1):15-24. doi:10.1021/acs.jnatprod.1c00377
5. International Journal of Cosmetic Science. Comprehensive review of the skin use of bakuchiol: physicochemical properties, sources, bioactivities, and regulatory status. Phytochemistry Reviews. 2024. doi:10.1007/s11101-024-09926-y